number of downloads : ?
language
eng
Author
Maruyama Dai Department of Hematology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan
Tsukasaki Kunihiro Department of Hematology, National Cancer Center Hospital East, Kashiwa, Japan
Uchida Toshiki Department of Hematology and Oncology, Japanese Red Cross Nagoya Daini Hospital, Nagoya, Japan
Maeda Yoshinobu Okayama University Hospital, Okayama, Japan View author publications
Shibayama Hirohiko Osaka University Hospital, Osaka, Japan
Nagai Hirokazu Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan
Kurosawa Mitsutoshi Hokkaido Cancer Center, Sapporo, Japan
Suehiro Yoko Kyushu Cancer Center, Fukuoka, Japan
Hatake Kiyohiko The Cancer Institute Hospital, Tokyo, Japan
Ando Kiyoshi Tokai University Hospital, Isehara, Japan
Yoshida Isao Shikoku Cancer Center, Matsuyama, Japan
Hidaka Michihiro Kumamoto Medical Center, Kumamoto, Japan
Murayama Tohru Hyogo Cancer Center, Akashi, Japan
Okitsu Yoko Tohoku University Hospital, Sendai, Japan
Tsukamoto Norifumi Gunma University Hospital, Maebashi, Japan
Taniwaki Masafumi University Hospital, Kyoto Prefectural University of Medicine, Kyoto, Japan
Tamura Kazuo Fukuoka University Hospital, Fukuoka, Japan
Yamauchi Takahiro Fukui University Hospital, Fukui, Japan
Ueda Ryuzo Aichi Medical University, Nagakute, Japan
Tobinai Kensei Department of Hematology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan
Subject
Forodesine; Peripheral T cell lymphoma; Overall response rate; Progression-free survival; Purine nucleoside phosphorylase inhibitor
Journal Title
ANNALS OF HEMATOLOGY
Volume
98
Issue
1
Start Page
131
End Page
142
ISSN
0939-5555
ISSN(Online)
1432-0584
Published Date
2019-01
DOI
PubMed ID
Publisher
SPRINGER
NII Type
Journal Article
OAI-PMH Set
Faculty of Medicine
Remark
This work was supported by Mundipharma K.K., Tokyo, Japan.